butyric acid has been researched along with Metastase in 9 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We found that polar compounds and butyric acid, which are known to alter the expressions of normally silent genes, enhanced the lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells." | 4.77 | Modification of the metastatic potential of tumor cells by drugs. ( Takenaga, K, 1986) |
| "The purpose is to evaluate the CD44-mediated cellular targeting of HA-But, a hyaluronic acid esterified with butyric acid (But) residues, to hepatocellular carcinoma cell lines in vitro and to hepatic tumor metastases in vivo." | 3.72 | Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. ( Bello, M; Cantoni, S; Coradini, D; Mazzi, U; Pellizzaro, C; Perbellini, A; Rossin, R; Sava, G; Scarlata, I; Speranza, A; Turrin, C; Zorzet, S, 2004) |
| "In the present investigation we have determined the effects of the differentiation-inducing chemicals dimethyl sulfoxide (DMSO) and sodium butyrate on the growth and tumorigenicity of a highly malignant/metastatic cell line (RAW117-H10) and its less tumorigenic parental lymphoma cell line (RAW117-P)." | 3.67 | Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells. ( Brunson, KW; Joshi, SS; Mathews, NB; Sharp, JG; Sinangil, F; Volsky, DJ, 1988) |
| "Metastasis is a leading cause of mortality in patients with lung adenocarcinoma." | 1.91 | Histone deacetylase inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1. ( Cao, Y; Duan, S; Fu, W; Meng, M; Tang, L; Wang, D; Wang, X; Yang, Y; Zhang, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Nudelman, A | 1 |
| Ruse, M | 1 |
| Aviram, A | 1 |
| Rabizadeh, E | 1 |
| Shaklai, M | 1 |
| Zimrah, Y | 1 |
| Rephaeli, A | 1 |
| Campbell, CT | 1 |
| Aich, U | 1 |
| Weier, CA | 1 |
| Wang, JJ | 1 |
| Choi, SS | 1 |
| Wen, MM | 1 |
| Maisel, K | 1 |
| Sampathkumar, SG | 1 |
| Yarema, KJ | 1 |
| Wang, D | 1 |
| Yang, Y | 1 |
| Cao, Y | 1 |
| Meng, M | 1 |
| Wang, X | 1 |
| Zhang, Z | 1 |
| Fu, W | 1 |
| Duan, S | 1 |
| Tang, L | 1 |
| Coradini, D | 1 |
| Zorzet, S | 1 |
| Rossin, R | 1 |
| Scarlata, I | 1 |
| Pellizzaro, C | 1 |
| Turrin, C | 1 |
| Bello, M | 1 |
| Cantoni, S | 1 |
| Speranza, A | 1 |
| Sava, G | 1 |
| Mazzi, U | 1 |
| Perbellini, A | 1 |
| Abe, M | 1 |
| Kufe, DW | 1 |
| Takenaga, K | 3 |
| Nakamura, Y | 1 |
| Sakiyama, S | 1 |
| Joshi, SS | 1 |
| Sinangil, F | 1 |
| Sharp, JG | 1 |
| Mathews, NB | 1 |
| Volsky, DJ | 1 |
| Brunson, KW | 1 |
1 review available for butyric acid and Metastase
| Article | Year |
|---|---|
Modification of the metastatic potential of tumor cells by drugs.
Topics: Animals; Azacitidine; Butyrates; Butyric Acid; Carcinoma; Cell Division; Cell Line; Cells, Cultured; | 1986 |
8 other studies available for butyric acid and Metastase
| Article | Year |
|---|---|
Novel anticancer prodrugs of butyric acid. 2.
Topics: Animals; Antineoplastic Agents; Butyrates; Cell Differentiation; Cell Division; Female; Humans; Leuk | 1992 |
Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; E | 2008 |
Histone deacetylase inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1.
Topics: Adenocarcinoma of Lung; Animals; Antigens, CD; Butyric Acid; Cadherins; Cell Movement; Epithelial-Me | 2023 |
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But.
Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Surv | 2004 |
Sodium butyrate induction of milk-related antigens in human MCF-7 breast carcinoma cells.
Topics: Antibodies, Monoclonal; Antigens, Surface; Breast Neoplasms; Butyrates; Butyric Acid; Cell Division; | 1984 |
Differential expression of a tropomyosin isoform in low- and high-metastatic Lewis lung carcinoma cells.
Topics: Animals; Butyrates; Butyric Acid; Cell Division; Dimethyl Sulfoxide; Electrophoresis, Polyacrylamide | 1988 |
Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells.
Topics: Animals; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Cell Line; Cytotoxicity, Immu | 1988 |
Effect of butyric acid on lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells.
Topics: Animals; Butyrates; Butyric Acid; Cathepsins; Cell Adhesion; Cycloheximide; Endothelium; Fatty Acids | 1986 |